Actinium Pharmaceuticals (ATNM) Share-based Compensation (2012 - 2026)
Actinium Pharmaceuticals (ATNM) reported Share-based Compensation of $118,000 for Q2 2026, down 40.1% from $197,000 a year earlier but up 972.7% from the prior quarter.
Actinium Pharmaceuticals (ATNM) Share-based Compensation (2012 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Actinium Pharmaceuticals' Share-based Compensation came in at $248,000, down 97.9% year-over-year; for FY2025, it came in at $9.19 million, up 73.7% from FY2024.
- Share-based Compensation has increased for five consecutive years, with a five-year compound annual growth rate of 48.9% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $5.29 million in FY2024 (+37.7%), $3.84 million in FY2023 (+37.5%), $2.8 million in FY2022 (+65.0%) and $1.69 million in FY2021 (+35.1%).
- Five-year quarterly Share-based Compensation spans a low of $10,000 in Q4 2025 and a high of $8.87 million in Q1 2025.
- Year over year, Share-based Compensation has now declined in each of the last five quarters, with growth averaging 25.3% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q1 2025 (growth of 544.0%); the low point was Q1 2026 (a decline of 99.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $11,000 (Q1 2026), $10,000 (Q4 2025) and $109,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Actinium Pharmaceuticals | 37.10 Mn | 37.10 Mn | - | 118,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 118,000.00 |
| Mar 31, 2026 | 11,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | 109,000.00 |
| Jun 30, 2025 | 197,000.00 |
| Mar 31, 2025 | 8.87 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.37 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Dec 31, 2023 | 927,000.00 |
| Sep 30, 2023 | 921,000.00 |
| Jun 30, 2023 | 1.00 Mn |
| Mar 31, 2023 | 993,000.00 |
| Dec 31, 2022 | 979,000.00 |
| Sep 30, 2022 | 970,000.00 |
| Jun 30, 2022 | 425,000.00 |
| Mar 31, 2022 | 421,000.00 |
| Dec 31, 2021 | 448,000.00 |
| Sep 30, 2021 | 411,000.00 |
Actinium Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ATNM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();